Laser Resurfacing for Darker Skin: Laser Resurfacing for Darker Skin

The answer

Is laser resurfacing safe for darker skin?

Laser resurfacing can be considered for darker skin, but it carries pigment-change and scarring risks that depend on the device, settings and treatment plan. Mayo warns that brown or Black skin has greater risk of lasting pigment changes. Neither fractional nor nonablative means risk-free.

The useful consultation starts with the concern you want treated and your own history of pigmentation, rather than a blanket yes or no based on skin color. Ask whether the clinician is treating depressed acne scars, melasma, another kind of discoloration or texture. Those are different problems. AAD explains that irritation or injury can itself trigger extra pigment in medium or dark skin. A treatment intended to improve a mark can therefore create a new pigment problem. Mayo recommends a clinician experienced across skin colors. Ask how that experience relates to the exact device and concern being discussed, and how the office monitors and manages unexpected changes. The evidence summarized here includes small selected studies, rather than an individual prediction. It does not justify calling every CO2 treatment unsuitable or every nonablative treatment safe. If the proposed benefit is uncertain, ask the clinician to explain alternatives and the option of waiting. A useful answer describes the expected gain and the specific risks you would be accepting to pursue it.

Your skin

What does Fitzpatrick skin type mean for laser resurfacing?

Fitzpatrick skin type describes the tendency to burn and ability to tan, rather than assigning a treatment category from race alone. The skin-typing review also notes limitations of subjective classification. You cannot determine your personal laser risk from a skin-color swatch or this page’s drawing.

The diagram deliberately uses neutral faces rather than a gradient that tells you which type you are. The categories help explain how studies describe their participants, but they do not supply a complete clinical assessment. A trial enrolling types IV–VI also does not necessarily include enough people in each category to estimate separate risks. Ask the clinician how it assessed your skin and what additional history matters for the proposed treatment. Your past response to inflammation, previous procedures and the condition being treated belong in that discussion. A review focused on types V–VI found that much of the published nonwhite laser literature involved East Asian patients and identified limited data in people of African ancestry. A broad label such as skin of color should not hide that gap. If a website claims universal suitability across skin types, ask which device, treatment settings and evidence it means. The drawing is a way to read the literature’s labels, rather than a self-assessment tool or a scale of how risky your skin is.

Your treatment

Does fractional laser resurfacing remove darker-skin risk?

Fractional resurfacing leaves skin between treatment columns, but it does not eliminate pigment risk in darker skin. ASLMS defines fractional as a coverage pattern. Mayo and the Aesthetic Society distinguish ablative removal from nonablative heating; either approach can use fractional delivery.

Ask the office to name the laser, its model and the planned mode. A CO2 treatment can be fractional while still ablating tissue. Nonablative fractional treatment heats tissue in columns without the same surface vaporization, yet the darker-skin acne-scar trial still recorded hyperpigmentation. This is why a brand name or the word fractional cannot settle the decision. Settings and the condition being treated also matter. The skin-layer drawing explains the relationship between the surface and treatment columns without claiming measured depths, ideal density or a safe intensity for you. A clinician should be able to connect the proposed mechanism to the feature you want improved and explain why it is preferable to another approach in your circumstances. Ask separately what recovery the proposed treatment creates, because preserved tissue between columns does not mean there is no need for aftercare. If you are comparing CO2 with Fraxel, the companion comparison page keeps the device identity and delivery pattern distinct. Carry that distinction into any written quote or consent discussion.

Go deeperCompare fractional CO2 and Fraxel Dual

What the studies measured

What did the darker-skin fractional laser trial find?

A randomized, blinded split-face acne-scar trial published in 2016 reported hyperpigmentation on five of seven higher-density sides and three of seven lower-density sides. The participants had Fitzpatrick types IV–VI. These were the same seven paired patients, rather than separate groups of people.

Both sides received nonablative fractional treatment at the same fluence, with density varied between sides. The study found statistically similar scar improvement at the tested densities. Its small size prevents treating that finding as proof that every lower-density protocol is equally effective. It also cannot establish a personal chance of pigmentation, a risk for every type separately or a direct comparison with CO2. Adding the higher- and lower-density reactions would double-count people who could have reacted on both sides. Keep the unit as treated sides in paired patients. The authors describe the pigment reactions as self-limited, but their experience cannot promise that an unexpected change in your skin will resolve on a schedule. Ask the clinician what this particular study changes about the treatment it would offer you. If the explanation is simply that nonablative lasers do not cause pigmentation, these results are a reason to ask for a more specific answer. The trial supports a discussion of density and follow-up, rather than a setting you should copy from an article.

What the studies measured

Does the darker-skin Fraxel study mean my risk is 4%?

The 4% figure from the 2013 darker-skin Fraxel re:store chart review is a rounded frequency per treatment session, not a patient’s personal risk. The review included 45 patients receiving 115 sessions and recorded hyperpigmentation with five sessions. Two episodes occurred in one patient.

The study used a specific treatment protocol, including hydroquinone before and after treatment. Its findings therefore cannot be separated from those settings and preparation. This is not a reason to start hydroquinone yourself or assume the same preparation suits you. Ask the treating clinician what it proposes and why. The chart review differs from the paired trial in design, treatment details and units: sessions in a retrospective review cannot be pooled with treated sides in a randomized trial. The review reported that only one episode lasted beyond a month, lasting two months. That observed episode duration is not a deadline by which your own pigment must clear. Repeated sessions also mean the denominator of visits is larger than the number of people exposed. Ask whether any risk number the office quotes counts people, visits or sides, and whether the same person can appear more than once. That question helps distinguish a reassuring-sounding percentage from evidence that actually fits your proposed care. It does not require you to decide your own suitability from a paper.

Different pigment problems

Can laser resurfacing treat dark marks or melasma?

Dark marks, melasma and depressed acne scars need different treatment discussions. AAD describes laser or light as an add-on for selected melasma patients already using medication and sun protection. It does not describe resurfacing as a standalone melasma cure or a way to erase every dark mark.

Start with a diagnosis. AAD advises confirming that a presumed age spot really is an age spot before treating it, and explains that inflammation or irritation can trigger extra pigment in medium or dark skin. The color left after acne can therefore be a different target from a depression in the skin. Ask the clinician which problem it sees and what nonlaser treatment is part of the plan. AAD says there is no single best melasma treatment, and the corrected review material identifies limited follow-up for recurrence. A result photograph soon after treatment cannot settle long-term control. AAD’s general advice about dark spots fading after their cause is stopped should also not become a laser-induced pigment recovery promise. The cause may still be active, and the diagnosis may differ. If pigmentation becomes darker, lighter or uneven after treatment, contact the treating clinician for assessment rather than adding acids, bleaching products or another procedure on your own. The question is what changed and how to manage it in your skin, not whether an online photograph looks similar.

Before and after

How should darker skin be prepared for laser resurfacing?

Darker-skin laser preparation needs a clinician’s plan for the diagnosis, recent sun exposure, medicines and aftercare. AAD warns that laser treatment on tanned or sunburned skin can cause a serious burn or discoloration. A preparation regimen from a study should not become a self-treatment prescription.

Tell the office about previous pigment reactions and procedures, then ask what should be paused or continued and who is responsible for that advice. The chart review’s use of hydroquinone is evidence of its protocol, rather than a requirement for everyone. MSK asks patients to disclose herpes or shingles in the treatment area and describes prescribed antiviral care when appropriate. Do not independently start, stop or substitute medication from a recovery story. Ask which products may touch the skin while it heals and when sunscreen can be applied to the treated area. Mayo discusses tinted iron-oxide or titanium-dioxide sunscreen for brown or Black skin in melasma and pigment protection, while AAD describes iron-oxide tint for visible-light protection. A product choice does not eliminate treatment risk. Get the actual aftercare plan before booking so that you can judge whether it fits your daily life. Ask how follow-up is arranged, including when you are traveling or the office is closed. Preparation should include a contact route, not just a shopping list.

Before and after

When should I call about pigment changes after laser resurfacing?

Contact your treating clinician about unexpected darkening, light patches, new scars or delayed healing after laser resurfacing. Call promptly for fever, chills, increased pain, redness or swelling, green or yellow drainage, or persistent bleeding, as MSK instructs. Do not wait for a study’s pigment timeline to expire.

Pigment change, infection and abnormal healing cannot be distinguished reliably from a comment thread or a photograph alone. MSK’s contact triggers and the Aesthetic Society’s warnings about unexpected color change are reasons to ask the treating team for an assessment. Tell the office when the change started, whether it is worsening and which products you have applied. Ask how it wants to examine or document the area. If you are already using a prescribed medicine, AAD advises speaking to the prescriber before stopping it because you suspect dark spots. A promise that every pigment change is temporary is stronger than the evidence supports. Mayo warns that lasting changes are possible. Before treatment, ask who handles this follow-up and what the office includes if additional care is needed. The supplied research does not establish a universal correction plan or refund policy. The broader candidacy, cost and recovery guides help you discuss those parts of the decision. You can also ask to see later follow-up images of patients treated for a similar concern, with the device and other treatments identified.